BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 31649559)

  • 1. Hepcidin and Anemia: A Tight Relationship.
    Pagani A; Nai A; Silvestri L; Camaschella C
    Front Physiol; 2019; 10():1294. PubMed ID: 31649559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutual control of iron and erythropoiesis.
    Camaschella C; Pagani A; Nai A; Silvestri L
    Int J Lab Hematol; 2016 May; 38 Suppl 1():20-6. PubMed ID: 27161430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels.
    Lira Zidanes A; Marchi G; Busti F; Marchetto A; Fermo E; Giorgetti A; Vianello A; Castagna A; Olivieri O; Bianchi P; Girelli D
    Front Physiol; 2020; 11():581386. PubMed ID: 33281618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mutual crosstalk between iron and erythropoiesis.
    Camaschella C; Pagani A; Silvestri L; Nai A
    Int J Hematol; 2022 Aug; 116(2):182-191. PubMed ID: 35618957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ineffective erythropoiesis and its treatment.
    Cazzola M
    Blood; 2022 Apr; 139(16):2460-2470. PubMed ID: 34932791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron metabolism and iron disorders revisited in the hepcidin era.
    Camaschella C; Nai A; Silvestri L
    Haematologica; 2020; 105(2):260-272. PubMed ID: 31949017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver iron sensing and body iron homeostasis.
    Wang CY; Babitt JL
    Blood; 2019 Jan; 133(1):18-29. PubMed ID: 30401708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
    Olivera J; Zhang V; Nemeth E; Ganz T
    Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Targeting of the Hepcidin/Ferroportin Axis.
    Sebastiani G; Wilkinson N; Pantopoulos K
    Front Pharmacol; 2016; 7():160. PubMed ID: 27445804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin and the BMP-SMAD pathway: An unexpected liaison.
    Silvestri L; Nai A; Dulja A; Pagani A
    Vitam Horm; 2019; 110():71-99. PubMed ID: 30798817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megaloblastic anemia-related iron overload and erythroid regulators: a case report.
    Vallet N; Delaye JB; Ropert M; Foucault A; Ravalet N; Deriaz S; Chalopin T; Blasco H; Maillot F; Hérault O; Gyan E
    J Med Case Rep; 2021 Sep; 15(1):463. PubMed ID: 34538261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietic regulators of iron metabolism.
    Ganz T
    Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.
    Porter J; Taher A; Viprakasit V; Kattamis A; Coates TD; Garbowski M; Dürrenberger F; Manolova V; Richard F; Cappellini MD
    Expert Rev Hematol; 2021 Jul; 14(7):633-644. PubMed ID: 34324404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iron metabolism: State of the art].
    Beaumont C; Karim Z
    Rev Med Interne; 2013 Jan; 34(1):17-25. PubMed ID: 22595534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.
    Camaschella C; Nai A
    Br J Haematol; 2016 Feb; 172(4):512-23. PubMed ID: 26491866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare anemias due to genetic iron metabolism defects.
    Brissot P; Bernard DG; Brissot E; Loréal O; Troadec MB
    Mutat Res Rev Mutat Res; 2018; 777():52-63. PubMed ID: 30115430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Hepcidin by Erythropoiesis: The Story So Far.
    Pasricha SR; McHugh K; Drakesmith H
    Annu Rev Nutr; 2016 Jul; 36():417-34. PubMed ID: 27146013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary hepcidin in congenital chronic anemias.
    Kearney SL; Nemeth E; Neufeld EJ; Thapa D; Ganz T; Weinstein DA; Cunningham MJ
    Pediatr Blood Cancer; 2007 Jan; 48(1):57-63. PubMed ID: 16220548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.